Class II
Ongoing
Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA.
Why: Subpotent Drug
- Company
- Major Pharmaceuticals
Dublin, OH, United States - Reported
- Jul 29, 2026
- Recall started
- Jul 13, 2026
- Where sold
- Nationwide in the USA.
- Amount
- N/A
- Full product description
- Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg), 100 Tablets (10 x 10 unit dose blisters) per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. NDC: 0904-6950-61
- Lots / codes affected
- Lot #: N02200, Exp. Date 10/2026
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.